NCT05306782

Brief Summary

Developmental stuttering (DS) is a motor/speech disorder, characterized by specific alterations in the functioning of brain circuits. Non-invasive brain stimulation may be useful to shape the altered functioning and connectivity of these systems. As a consequence, this project aims to expand the neurophysiological understanding of DS, evaluating effects of transcranial electrical stimulation (tES) on speech fluency and brain functioning of adults with persistent DS. This project will provide high-impact insights into the functioning of DS neural system, also proposing innovative and/or personalized rehabilitation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 1, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

April 2, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

October 2, 2024

Status Verified

October 1, 2024

Enrollment Period

2.4 years

First QC Date

February 26, 2022

Last Update Submit

October 1, 2024

Conditions

Keywords

Developmental StutteringNeuromodulationtranscranial Electrical StimulationSpeech FluencyMotor Networks

Outcome Measures

Primary Outcomes (3)

  • Speech Fluency and Stuttering Severity (change from baseline)

    Utilization of (objective) scales to evaluate stuttering severity and speech fluency (Stuttering Severity Instrument \[range 0-56; higher values indicate higher numbers of dysfluencies\])

    Evaluated immediately after the end of treatments

  • TMS-induced (Motor) Evoked Potentials (change from baseline)

    Utilization of Transcranial Magnetic Stimulation to evaluate excitability (and reactivity) of motor cortex

    Evaluated immediately after the end of treatments

  • EEG (change from baseline)

    Utilization of EEG to evaluate brain functioning and brain connectivity (delta, theta, alpha, beta, and gamma activity)

    Evaluated immediately after the end of treatments

Secondary Outcomes (7)

  • Stuttering Severity (subjective perception) (change from baseline)

    Evaluated immediately after the end of treatments

  • Stuttering Severity (subjective perception) (change from baseline)

    Evaluated about 6 weeks after the end of treatments

  • Speech Fluency and Stuttering Severity (change from baseline)

    Evaluated about 6 weeks after the end of treatments

  • TMS-induced (Motor) Evoked Potentials (change from baseline)

    Evaluated about 6 weeks after the end of treatments

  • EEG (change from baseline)

    Evaluated about 6 weeks after the end of treatments

  • +2 more secondary outcomes

Study Arms (3)

Transcranial Random Noise Stimulation

EXPERIMENTAL

Transcranial Random Noise Stimulation (1.5 mA, High Frequency) administered by using surface scalp electrodes (20 minutes, initial part of the session) in correspondence of associative motor regions, during speech therapy sessions (45 minutes).

Device: transcranial Electrical StimulationBehavioral: Speech Therapy

Transcranial Direct Current Stimulation

EXPERIMENTAL

Transcranial Direct Current Stimulation (1.5 mA, anodal) administered by using surface scalp electrodes (20 minutes, initial part of the session) in correspondence of associative motor regions, during speech therapy sessions (45 minutes).

Device: transcranial Electrical StimulationBehavioral: Speech Therapy

Sham Direct Current/Random Noise Stimulation

SHAM COMPARATOR

Sham stimulation administered by using surface scalp electrodes (20 minutes, initial part of the session) in correspondence of associative motor regions, during speech therapy sessions (45 minutes).

Device: transcranial Electrical StimulationBehavioral: Speech Therapy

Interventions

transcranial Random Noise Stimulation, transcranial Direct Current Stimulation, or Sham are administered (by means of surface electrodes) on associative motor regions during speech therapy sessions (20 minutes, in the initial part of the sessions; 1.5 mA).

Sham Direct Current/Random Noise StimulationTranscranial Direct Current StimulationTranscranial Random Noise Stimulation
Speech TherapyBEHAVIORAL

Speech Therapy is associated to transcranial electrical stimulation or sham, during stimulation sessions. Total duration of the single session: 45 minutes

Sham Direct Current/Random Noise StimulationTranscranial Direct Current StimulationTranscranial Random Noise Stimulation

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Right-handed adults with idiopathic, persistent DS since childhood

You may not qualify if:

  • Contraindications to non-invasive brain stimulation;
  • Currently assumption of drugs acting on the Central Nervous System;
  • Presence of overt neurological/psychiatric/medical conditions or overt comorbidities (e.g. obsessive-compulsive disorder).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Ospedale San Camillo

Venice, 30126, Italy

Location

MeSH Terms

Conditions

Stuttering

Interventions

Transcranial Direct Current StimulationSpeech Therapy

Condition Hierarchy (Ancestors)

Speech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesRehabilitation of Speech and Language DisordersRehabilitationAftercareContinuity of Patient CarePatient Care

Study Officials

  • Pierpaolo Busan, Dr.

    IRCCS Ospedale San Camillo s.r.l.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants will be randomly assigned to "real" neuromodulation or to "sham" modulation (in addition to speech therapy)
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 26, 2022

First Posted

April 1, 2022

Study Start

April 2, 2022

Primary Completion

August 31, 2024

Study Completion

September 30, 2024

Last Updated

October 2, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations